Smith & Nephew plc revenue by segment SNN

Annual Quarterly

Smith & Nephew plc splits its revenue 2 ways in its filings. By operating segments, the largest line in fiscal 2025, which ended Dec 31, 2025 was Orthopaedics at $2.4 billion, 40% of the total. By sales mix, the largest line in fiscal 2025, which ended Dec 31, 2025 was Sports Medicine Joint Repair at $1.1 billion, 17% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018	FY 2017 Dec 31, 2017
Revenue	6,164	5,810	5,549	5,215	5,212	4,560	5,138	4,904	4,765
Operating segments
Orthopaedics	2,437 +5.7% share 39.5%	2,305 +4.1% share 39.7%	2,214 +4.8% share 39.9%	2,113 -2.0% share 40.5%	2,156 +12.5% share 41.4%	1,917 -13.7% share 42.0%	2,222 share 43.2%	—	—
Sports Medicine And Ent	1,934 +6.0% share 31.4%	1,824 +5.5% share 31.4%	1,729 +8.7% share 31.2%	1,590 +1.9% share 30.5%	1,560 +17.0% share 29.9%	1,333 -13.2% share 29.2%	1,536 share 29.9%	—	—
Advanced Wound Management	1,793 +6.7% share 29.1%	1,681 +4.7% share 28.9%	1,606 +6.2% share 28.9%	1,512 +1.1% share 29.0%	1,496 +14.2% share 28.7%	1,310 -5.1% share 28.7%	1,380 share 26.9%	—	—
Sales mix
Sports Medicine Joint Repair	1,067 +8.7% share 17.3%	982 +3.9% share 16.9%	945 +8.6% share 17.0%	870 +3.7% share 16.7%	839 +18.2% share 16.1%	710 -10.6% share 15.6%	794 share 15.5%	—	—
Knee Implants	1,011 +3.5% share 16.4%	977 +3.9% share 16.8%	940 +4.6% share 16.9%	899 +2.6% share 17.2%	876 share 16.8%	—	1,042 share 20.3%	—	—
Advanced Wound Care	766 +4.2% share 12.4%	735 +1.4% share 12.7%	725 +1.8% share 13.1%	712 -2.6% share 13.7%	731 +13.0% share 14.0%	647 -7.7% share 14.2%	701 share 13.6%	—	—
Trauma	649 +6.7% share 10.5%	608 +7.8% share 10.5%	564 +3.9% share 10.2%	543 -5.7% share 10.4%	576 +25.2% share 11.1%	460 -5.7% share 10.1%	488 share 9.5%	—	—
Arthroscopic Enabling Technologies	647 +2.4% share 10.5%	632 +7.5% share 10.9%	588 +3.7% share 10.6%	567 -3.9% share 10.9%	590 +14.1% share 11.3%	517 -12.5% share 11.3%	591 share 11.5%	—	—
Hip Implants	641 +3.6% share 10.4%	619 +3.3% share 10.7%	599 +2.6% share 10.8%	584 -4.6% share 11.2%	612 share 11.7%	—	613 share 11.9%	—	—
Advanced Wound Bioactives	621 +6.9% share 10.1%	581 +5.1% share 10.0%	553 share 10.0%	—	496 +15.1% share 9.5%	431 -1.1% share 9.5%	436 share 8.5%	—	—
Advanced Wound Devices	406 +11.2% share 6.6%	365 +11.3% share 6.3%	328 +17.1% share 5.9%	280 +4.1% share 5.4%	269 +15.9% share 5.2%	232 -4.5% share 5.1%	243 share 4.7%	—	—
Ear Nose And Throat	220 +4.8% share 3.6%	210 +7.1% share 3.6%	196 +28.1% share 3.5%	153 +16.8% share 2.9%	131 +23.6% share 2.5%	106 -29.8% share 2.3%	151 share 2.9%	—	—
Other Reconstruction	136 +34.7% share 2.2%	101 -9.0% share 1.7%	111 +27.6% share 2.0%	87 -5.4% share 1.7%	92 +35.3% share 1.8%	68 -13.9% share 1.5%	79 share 1.5%	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. More on our methodology.

Company profile

Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as: SNN (NYSE), SNNUF (OTC)
Fiscal year ends: December 31
Headquarters: Watford, Hertfordshire
SEC filer status: Large accelerated filer
SEC CIK: 845982

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.